Yeonsil Moon1, Ye-Ji Choi2, Jin Ok Kim3, Seol-Heui Han4,5. 1. Department of Neurology, Konkuk University Medical Center, 120-1 Neungdong-ro, Gwangjin-gu, Seoul, 143-729, South Korea. 2. Department of Neurology, Kangnam General Hospital, Yongin, Kyunggido, South Korea. 3. Department of Neurology, Eulji University College of Medicine, Daejeon, South Korea. 4. Department of Neurology, Konkuk University Medical Center, 120-1 Neungdong-ro, Gwangjin-gu, Seoul, 143-729, South Korea. alzdoc@kuh.ac.kr. 5. Center for Geriatric Neuroscience Research, Institute of Biomedical Science, Konkuk Medical Science Research Center, Seoul, South Korea. alzdoc@kuh.ac.kr.
Abstract
INTRODUCTION: Neurodegenerative disease is one of the main contributing factors affecting muscle atrophy. However, this intriguing brain-muscle axis has been explained by the unsubstantial mechanisms. Although there have been several studies that have evaluated the muscle profile and its relation to cognition in patients with dementia, there is still lack of data using standardized methods and only few published studies on Korean populations. The objective of this study is to evaluate the relationship of muscle mass and strength to cognition in patients with Alzheimer's disease dementia (AD). METHODS: We recruited 91 patients with probable AD without weakness. We assessed patients' basic demographic characteristics, vascular risk, body mass index, and global cognitive assessment scores. Muscle mass was measured using body dual-energy X-ray absorptiometry. Muscle strength was assessed by isokinetic knee extensor using an isokinetic device at an angular velocity of 60°/s in nm/kg. RESULTS: The muscle mass and strength were not related to each other in both male and female groups. Only muscle strength, but not muscle mass, was negatively related to cognition. After adjusting for covariates, the relationship between muscle strength and cognition still remained in the male group, however, was attenuated in the female group. CONCLUSIONS: In patients with AD dementia, abundant muscle mass did not mean strong power. The simple lower-extremity muscle strength assessment is more effective in predicting cognition than a muscle mass measure in male patients.
INTRODUCTION:Neurodegenerative disease is one of the main contributing factors affecting muscle atrophy. However, this intriguing brain-muscle axis has been explained by the unsubstantial mechanisms. Although there have been several studies that have evaluated the muscle profile and its relation to cognition in patients with dementia, there is still lack of data using standardized methods and only few published studies on Korean populations. The objective of this study is to evaluate the relationship of muscle mass and strength to cognition in patients with Alzheimer's disease dementia (AD). METHODS: We recruited 91 patients with probable AD without weakness. We assessed patients' basic demographic characteristics, vascular risk, body mass index, and global cognitive assessment scores. Muscle mass was measured using body dual-energy X-ray absorptiometry. Muscle strength was assessed by isokinetic knee extensor using an isokinetic device at an angular velocity of 60°/s in nm/kg. RESULTS: The muscle mass and strength were not related to each other in both male and female groups. Only muscle strength, but not muscle mass, was negatively related to cognition. After adjusting for covariates, the relationship between muscle strength and cognition still remained in the male group, however, was attenuated in the female group. CONCLUSIONS: In patients with AD dementia, abundant muscle mass did not mean strong power. The simple lower-extremity muscle strength assessment is more effective in predicting cognition than a muscle mass measure in male patients.
Authors: Jaehee Kim; ZiMian Wang; Steven B Heymsfield; Richard N Baumgartner; Dympna Gallagher Journal: Am J Clin Nutr Date: 2002-08 Impact factor: 7.045
Authors: J C Menant; F Weber; J Lo; D L Sturnieks; J C Close; P S Sachdev; H Brodaty; S R Lord Journal: Osteoporos Int Date: 2016-07-09 Impact factor: 4.507
Authors: Soo Lim; Jung Hee Kim; Ji Won Yoon; Seon Mee Kang; Sung Hee Choi; Young Joo Park; Ki Woong Kim; Jae Young Lim; Kyong Soo Park; Hak Chul Jang Journal: Diabetes Care Date: 2010-05-11 Impact factor: 19.112
Authors: Andrew J Westwood; Alexa Beiser; Charles Decarli; Tamara B Harris; Tai C Chen; Xue-Mei He; Ronenn Roubenoff; Aleksandra Pikula; Rhoda Au; Lewis E Braverman; Philip A Wolf; Ramachandran S Vasan; Sudha Seshadri Journal: Neurology Date: 2014-04-04 Impact factor: 9.910
Authors: Michal S Beeri; Sue E Leugrans; Osvaldo Delbono; David A Bennett; Aron S Buchman Journal: J Am Geriatr Soc Date: 2021-05-05 Impact factor: 7.538